This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Palau Pharma, S.a., Vectura Gmbh. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2015
Title: Inventor Jorge Salas Solana: A Pioneer in JAK3 Kinase Inhibitors
Introduction
Jorge Salas Solana, a remarkable inventor based in Granollers, Spain, has made significant contributions to the field of pharmacology through his innovations. With a total of two patents to his name, Salas Solana is recognized for his work on N-containing heteroaryl derivatives that serve as effective JAK3 kinase inhibitors. His research is paving the way for new therapeutic strategies in treating various diseases.
Latest Patents
Salas Solana's latest patents focus on N-containing heteroaryl derivatives designed as JAK3 kinase inhibitors. These compounds, defined by specific formulas, exhibit unique substituent characteristics as disclosed in the respective descriptions. The innovative derivatives demonstrate substantial potential in inhibiting the JAK3 kinase, which plays a critical role in numerous cellular processes, making them valuable for therapeutic applications.
Career Highlights
Throughout his career, Jorge Salas Solana has worked with notable companies, including Vectura GmbH and Palau Pharma, S.A. His experiences in these organizations have undoubtedly enriched his expertise and bolstered his inventive capabilities. His focus on pharmaceutical development showcases his commitment to advancing healthcare solutions.
Collaborations
In the course of his professional journey, Salas Solana has collaborated with esteemed colleagues such as Carmen Almansa Rosales and Robert Soliva Soliva. These partnerships have facilitated the exchange of ideas and innovation, further contributing to the successes reflected in his patent portfolio.
Conclusion
Jorge Salas Solana stands out as a significant figure in the realm of biomedical innovation. His work on JAK3 kinase inhibitors exemplifies the vital role of inventors in developing new therapeutic agents. As he continues to forge ahead in his research, the impact of his inventions on healthcare is sure to grow, benefiting countless individuals in need of advanced medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile